SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

Molecular mechanisms underlying the antidepressant actions of

Signaling pathways responsible for the rapid antidepressant-like

NMDA receptor trafficking in synaptic plasticity and

SciELO - Brazil - Does mismatch negativity have utility for NMDA

PDF) Pharmacological treatment of generalized anxiety disorder

Ketamine and Other NMDA Antagonists: Early Clinical Trials and

The current state of research on ayahuasca: A systematic review of

Recent Findings in NMDA Receptor Research and Its Impact on the

NMDA receptor subunit diversity: impact on receptor properties

NMDA Receptor Modulators – The Liotta Research Group

SciELO - Brazil - Does mismatch negativity have utility for NMDA

Applied Sciences January-1 2021 - Browse Articles

Blockade of NMDA receptor or NMDA-DAPK1 downstream signaling